IA
AST.WS

IFP Advisors’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

IFP Advisors’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-262
Closed – – 4440
2017
Q3 		$0 Hold
262
– – ﹤0.01% 4429
2017
Q2 		$0 Hold
262
– – ﹤0.01% 4423
2017
Q1 		$0 Hold
262
– – ﹤0.01% 4365
2016
Q4 		$0 Hold
262
– – ﹤0.01% 4353
2016
Q3 		$0 Hold
262
– – ﹤0.01% 4270
2016
Q2 		$0 Buy
+262
New +$136 ﹤0.01% 4333

IFP Advisors's AST.WS Position: Q4 2017 in Review

IFP Advisors sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q4 2017, closing a stake of 262 shares.

IFP Advisors first reported a position in AST.WS in Q2 2016 and held it in 6 quarters. The position peaked at $0 in Q3 2017. 0 funds tracked by Wall St. Rank hold AST.WS as of Q4 2017.

  • IFP Advisors reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q4 2017 after selling out during the quarter.
  • IFP Advisors sold 262 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q4 2017.
  • IFP Advisors first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 6 quarters.
  • IFP Advisors's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q4 2017.

Based on IFP Advisors's 13F filing for Q4 2017, filed 24 Jan 2018.